News from Wyss Zurich

Simone Bottan wins the Venture Kick final

Sophie Gavarini, Communications Manager of Wyss Zurich

The Wyss Translational Center Zurich (also called Wyss Zurich) is a multidisciplinary research and development center of the University of Zurich and ETH Zurich, which was made possible by a generous donation from the Swiss entrepreneur and philanthropist Dr. hc. mult. Hansjörg Wyss.

Simone Bottan, Project co-Leader of the Wyss Zurich HeartOne project, convinced the distinguished jury at the Venture Kick final and won the third and last round of Venture Kick for his anti-fibrotic solution for implantable heart pumps. He raised CHF 130 000 in start capital, the maximum funding granted by Venture Kick.Venture Kick is a philanthropic initiative, which aims at early identification, structuring and promotion of promising business ideas. It is highly competitive. Each month, eight projects get the chance to present themselves to a jury. The four most promising then receive CHF 10 000 and qualify for the second round held three months later, where the two best teams receive another CHF 20 000 each. In the third and final round, taking place six months later, the winner is granted CHF 100 000.

Simone Bottan, co-Founder of the ETH Zurich spin-off HYLOMORPH AG, and his collaborators have developed an anti-fibrotic solution for soft tissue repair. In 2015, this project was integrated into the HeartOne project of Wyss Zurich for further development towards the clinic. The HeartOne project aims at improving heart pumps, notably by preventing implant-induced foreign body reactions, which significantly complicate subsequent surgeries and patient recovery. This technological advancement has the potential to dramatically improve safety and quality of life of patients with heart failure, while also reducing healthcare costs.

Many basic research discoveries and inventions do not get translated into commercial products because industry/investors typically prefer to invest in "riper" technologies. Often business creations or transfers fail due to lack of funding; and early stage developments get stuck in what is called the "Valley of Death". Venture Kick and Wyss Zurich help to fill this financial gap. Simone Bottan's project is a great example of a promising technology that is progressing toward the clinic thanks to the complementary support from Venture Kick and Wyss Zurich.

News Liste

Universität Zürich

Die Universität Zürich steht für international kompetitive Forschung und forschungsbasierte Lehre.